Ignite Creation Date:
2024-05-05 @ 11:19 AM
Last Modification Date:
2024-10-26 @ 9:02 AM
Study NCT ID:
NCT00002184
Status:
COMPLETED
Last Update Posted:
2005-06-24
First Post:
1999-11-02
Brief Title:
A Phase II Stratified Randomized Double-Blind Multi-Center Study of the Safety and Efficacy of Adefovir Dipivoxil ADF at Two Dose Levels in Triple Combination Therapies With Protease Inhibitors PI and Nucleoside Reverse Transcriptase Inhibitors RTI for the Treatment of HIV-Infected Patient
Sponsor:
Organization:
NIH AIDS Clinical Trials Information Service
Study Design
Study Type:
INTERVENTIONAL
Expanded Access Type Individual:
None
Expanded Access Type Intermediate:
None
Expanded Access Type Treatment:
None
Patient Registry:
None
Target Duration:
None
Design Allocation:
Design Intervention Model:
Design Intervention Model Description:
Design Masking Description:
Bio Spec Retention:
None
Bio Spec Description:
None
Enrollment Count:
120
Enrollment Type:
None
Design Primary Purpose:
Design Masking:
Phases:
| Name |
|---|
| PHASE2 |
Observational Models:
Time Perspective List:
Who Masked List: